Crescent Pharmaceuticals Limited in Basingstoke, RG21 8SR

Description

Data updated on: 01-11-2023

Crescent Pharmaceuticals Limited was set up as Private Limited Company, that is located in Key House, Sarum Hill, Basingstoke. The company's postal code is RG21 8SR. This firm was established in 2010. The company's registration number is 07117426. Started as Easyprime, the company used the name until 9th March 2010, when it got changed to Crescent Pharmaceuticals Limited. The firm's principal business activity number is 64209, that means Activities of other holding companies n.e.c.. 2022-12-31 is the last time the company accounts were reported.

As for this company, the majority of director's obligations have been performed by Laith A., Samie A. and Mohammed A.. Amongst these three people, Mohammed A. has carried on with the company for the longest period of time, having become a vital part of directors' team on 29th January 2010.

Previous company's names
Crescent Pharmaceuticals Limited 2010-03-09
Easyprime Limited 2010-01-06

Financial data based on annual reports

Profit & Loss
Date of Accounts	2020-12-31	2021-12-31
Currency

Balance Sheet
Debtors		150 000
Total Inventories	36 113 938	45 401 893

Other Financial Data
Accrued Liabilities Deferred Income	20 557 796	13 137 865
Accumulated Amortisation Impairment Intangible Assets	8 530 629	9 367 231
Accumulated Depreciation Impairment Property Plant Equipment	720 476	840 047
Acquired Through Business Combinations Property Plant Equipment		28 135
Additions Other Than Through Business Combinations Intangible Assets		3 600 000
Additions Other Than Through Business Combinations Property Plant Equipment		24 415
Administrative Expenses	21 167 267	11 487 798
Amounts Owed To Group Undertakings		1 003 427
Average Number Employees During Period
Bank Borrowings Overdrafts		170 318
Bank Overdrafts		13 622
Carrying Amount Under Cost Model Revalued Assets Property Plant Equipment	51 717	25 095
Cash Cash Equivalents	9 467 601	3 527 970
Cash Flows From Disposal Or Reduction In Control Over Subsidiaries Or Other Businesses		853 427
Corporation Tax Payable	1 579 165
Corporation Tax Recoverable		1 342 622
Cost Sales	62 833 284	70 184 029
Current Tax For Period	2 356 354
Deferred Income	2 974 325	62 463
Deferred Tax Expense Credit From Unrecognised Timing Difference From Prior Period	27 769	1 078 429
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences	25 279	-11 195
Distribution Costs	12 252 079	11 286 209
Finance Lease Liabilities Present Value Total	55 231	13 126
Finance Lease Payments Owing Minimum Gross	7 397	42 105
Finished Goods Goods For Resale	36 113 938	45 401 893
Further Item Operating Income Gain Income Statement Item Component Operating Profit Loss		-3 600 000
Further Item Tax Increase Decrease Component Adjusting Items	-88 325	-925 901
Gain Loss On Disposals Property Plant Equipment	24 700	3 600
Gross Profit Loss	43 349 602	26 487 504
Impairment Loss Intangible Assets		3 600 000
Increase Decrease In Current Tax From Adjustment For Prior Periods	-28 175	-893 021
Increase From Amortisation Charge For Year Intangible Assets		836 602
Increase From Depreciation Charge For Year Property Plant Equipment		136 031
Increase From Impairment Loss Recognised In Profit Or Loss Intangible Assets		3 600 000
Intangible Assets	2 419 608	1 583 006
Intangible Assets Gross Cost	10 950 237	10 950 237
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings	95 248	99 326
Interest Income On Bank Deposits	4 257	100
Interest Paid Classified As Operating Activities	-389 189	-99 326
Interest Payable Similar Charges Finance Costs	95 248	99 326
Interest Received Classified As Investing Activities	-4 257	-100
Investments	1	853 428
Investments Fixed Assets	1	853 428
Investments In Joint Ventures	50
Investments In Subsidiaries	1	853 428
Net Finance Income Costs		100
Operating Profit Loss	13 022 571	512 497
Other Creditors	2 762 604	9 601 337
Other Creditors Including Taxation Social Security Balance Sheet Subtotal	4 675 802
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment		16 460
Other Disposals Property Plant Equipment		16 460
Other Interest Receivable Similar Income Finance Income	4 257	100
Other Remaining Borrowings		1 000 000
Pension Other Post-employment Benefit Costs Other Pension Costs	37 621	33 378
Percentage Class Share Held In Joint Venture
Percentage Class Share Held In Subsidiary	100	100
Prepayments Accrued Income	1 595 038	1 816 809
Profit Loss	10 787 571	1 317 487
Profit Loss On Ordinary Activities Before Tax	12 931 580	413 271
Property Plant Equipment Gross Cost	1 077 851	1 113 941
Social Security Costs	1 738 548	224 808
Staff Costs Employee Benefits Expense	14 778 576	2 379 491
Taxation Including Deferred Taxation Balance Sheet Subtotal	64 424	53 229
Tax Decrease Increase From Effect Revenue Exempt From Taxation		1 340
Tax Increase Decrease From Effect Capital Allowances Depreciation	12 085	12 887
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss	-29	-1 159 587
Tax Tax Credit On Profit Or Loss On Ordinary Activities	2 353 458	-904 216
Total Current Tax Expense Credit	2 328 179	-893 021
Trade Creditors Trade Payables	18 338 519	18 492 494
Trade Debtors Trade Receivables	12 326 007	17 336 402
Turnover Revenue	106 182 886	96 671 533
Wages Salaries	13 002 407	2 121 305

Company staff

Laith A.

Role: Director

Appointed: 25 January 2024

Latest update: 8 March 2024

Samie A.

Role: Director

Appointed: 25 January 2024

Latest update: 8 March 2024

Mohammed A.

Role: Director

Appointed: 29 January 2010

Latest update: 8 March 2024

Laith A.

Role: Director

Appointed: 30 October 2014

Resigned: 30 October 2014

Latest update: 8 March 2024

Bharat S.

Role: Director

Appointed: 29 January 2010

Resigned: 01 September 2013

Latest update: 8 March 2024

Andrew D.

Role: Director

Appointed: 06 January 2010

Resigned: 29 January 2010

Latest update: 8 March 2024

People with significant control

Executives who have control over this firm are as follows: Laith A. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Samie A. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Mohammed A. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Laith A.

Notified on 26 February 2024

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Samie A.

Notified on 26 February 2024

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Mohammed A.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	15 January 2024
Confirmation statement last made up date	01 January 2023

Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	2019-12-31
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	2020-12-31
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-31

Crescent Pharmaceuticals Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Laith A.

Samie A.

Mohammed A.

Laith A.

Bharat S.

Andrew D.

People with significant control

Laith A.

Samie A.

Mohammed A.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode